Sign inSubmit
ArticleMetrics
Review Article · Open access · Published 24 February 2024

Long Way of Evaluating Niacin for Atherosclerosis Treatment

Anastasia Vladimirovna Poznyak1, Victoria Alexandrovna Khotina2, Elizaveta Mikhailovna Pleshko3, Vasily Nikolaevich Sukhorukov3, Victor Yurievich Glanz3 & Alexander Nikolaevich Orekhov3

OnLine Journal of Biological Sciences, Volume 24, Issue 3, pp. 349–357 · doi.org/10.3844/ojbsci.2024.349.357

5,122 accesses2,939 downloads0 citations (Crossref)Metrics
Cite Check for updates

Abstract

Atherosclerosis is a significant public health challenge, as it is closely associated with a wide range of cardiovascular diseases and complications. Despite its grave implications, the timely detection and treatment of atherosclerosis remain complex tasks due to the intricate pathogenesis involved, which encompasses numerous processes and mechanisms. Extensive research has been conducted to investigate various therapeutic methods and drugs aimed at targeting both the overall progression of the disease and specific pathogenic mechanisms. Recognizing the multifaceted nature of atherosclerosis, comprehensive treatment approaches have emerged as essential in effectively managing the condition. This review provides a thorough examination of the mechanisms underlying the action of niacin, a potential therapeutic agent, in the treatment of atherosclerosis. By illuminating the specific modes of action of niacin, this review contributes to our understanding of its promising role as a treatment modality for atherosclerosis and offers insights into its potential clinical applications.

Licence and reuse

Open access. This article is licensed under a Creative Commons Attribution 4.0 International Licence (CC BY 4.0), as printed on the article, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original authors and the source. No permission is needed.

How to reuse this article

Responses (0)

Have a comment on this research? Sign in to respond. Responses are moderated and published with your name and affiliation; the authors are invited to reply. How we use your dataWrite a response

About this article

Cite this article

Poznyak, A. V., Khotina, V. A., Pleshko, E. M., Sukhorukov, V. N., Glanz, V. Y. & Orekhov, A. N. (2024). Long Way of Evaluating Niacin for Atherosclerosis Treatment. OnLine Journal of Biological Sciences, 24(3), 349–357. https://doi.org/10.3844/ojbsci.2024.349.357

Licence
CC BY 4.0
Issue
Volume 24, Issue 3
Policies
Editorial independenceUse of generative AIData availabilityAppeals and complaints
Version
Version of record
Long Way of Evaluating Niacin for Atherosclerosis TreatmentOnLine Journal of Biological Sciences · Volume 24, Issue 3 · pp. 349–357 · CC BY 4.0Download